These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 19547711)

  • 21. Early diagnosis of paediatric HIV-1 infection among African breast-fed children using a quantitative plasma HIV RNA assay.
    Rouet F; Montcho C; Rouzioux C; Leroy V; Msellati P; Kottan JB; You B; Viho I; Dabis F;
    AIDS; 2001 Sep; 15(14):1849-56. PubMed ID: 11579248
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of human immunodeficiency virus assays in window phase and elite controller samples: viral load distribution and implications for transmission risk.
    Vermeulen M; Coleman C; Mitchel J; Reddy R; van Drimmelen H; Fickett T; Busch M; Lelie N
    Transfusion; 2013 Oct; 53(10 Pt 2):2384-98. PubMed ID: 23445273
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of hepatitis C viremia using molecular amplification technologies: correlations and clinical implications.
    Gretch DR; dela Rosa C; Carithers RL; Willson RA; Williams B; Corey L
    Ann Intern Med; 1995 Sep; 123(5):321-9. PubMed ID: 7542853
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the Quantiplex version 3.0 assay and a sensitized Amplicor monitor assay for measurement of human immunodeficiency virus type 1 RNA levels in plasma samples.
    Highbarger HC; Alvord WG; Jiang MK; Shah AS; Metcalf JA; Lane HC; Dewar RL
    J Clin Microbiol; 1999 Nov; 37(11):3612-4. PubMed ID: 10523562
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative evaluation of the QUANTIPLEX HIV-1 RNA 2.0 and 3.0 (bDNA) assays and the AMPLICOR HIV-1 MONITOR v1.5 test for the quantitation of human immunodeficiency virus type 1 RNA in plasma.
    Anastassopoulou CG; Touloumi G; Katsoulidou A; Hatzitheodorou H; Pappa M; Paraskevis D; Lazanas M; Gargalianos P; Hatzakis A
    J Virol Methods; 2001 Jan; 91(1):67-74. PubMed ID: 11164487
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative analysis of HIV-1 viral load assays on subtype quantification: Bayer Versant HIV-1 RNA 3.0 versus Roche Amplicor HIV-1 Monitor version 1.5.
    Elbeik T; Alvord WG; Trichavaroj R; de Souza M; Dewar R; Brown A; Chernoff D; Michael NL; Nassos P; Hadley K; Ng VL
    J Acquir Immune Defic Syndr; 2002 Apr; 29(4):330-9. PubMed ID: 11917236
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The quantification of human immunodeficiency virus viremia in patients with rapid and slow progression of the disease].
    Bravo R; Soriano V; Martín R; del Romero J; Dronda F; Gutiérrez M; Martínez P; Valencia E; Moreno V; Laguna F
    Med Clin (Barc); 1995 Apr; 104(14):530-4. PubMed ID: 7776732
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A reverse-transcription competitive PCR assay based on chemiluminescence hybridization for detection and quantification of hepatitis C virus RNA.
    Young KC; Chang TT; Hsiao WC; Cheng PN; Chen SH; Jen CM
    J Virol Methods; 2002 May; 103(1):27-39. PubMed ID: 11906730
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HIV-1 drug resistance profiles in children and adults with viral load of <50 copies/ml receiving combination therapy.
    Hermankova M; Ray SC; Ruff C; Powell-Davis M; Ingersoll R; D'Aquila RT; Quinn TC; Siliciano JD; Siliciano RF; Persaud D
    JAMA; 2001 Jul; 286(2):196-207. PubMed ID: 11448283
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantification of hepatitis C virus RNA by RT-PCR in comparison to the branched DNA method.
    Roth WK; Lee JH; Rüster B; Zeuzem S
    Z Gastroenterol; 1998 Jan; 36(1):5-11. PubMed ID: 9531684
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The significance of HIV viral load assay precision: a review of the package insert specifications of two commercial kits.
    Chernoff DN
    J Int Assoc Physicians AIDS Care (Chic); 2002; 1(4):134-40. PubMed ID: 12942672
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of three different commercial methods for measuring plasma viraemia in patients infected with non-B HIV-1 subtypes.
    Holguín A; de Mendoza C; Soriano V
    Eur J Clin Microbiol Infect Dis; 1999 Apr; 18(4):256-9. PubMed ID: 10385013
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantification of HIV-DNA and residual viremia in patients starting ART by droplet digital PCR: Their dynamic decay and correlations with immunological parameters and virological success.
    Alteri C; Scutari R; Stingone C; Maffongelli G; Brugneti M; Falasca F; Martini S; Bertoli A; Turriziani O; Sarmati L; Coppola N; Andreoni M; Santoro MM; Perno CF; Ceccherini-Silberstein F; Svicher V
    J Clin Virol; 2019 Aug; 117():61-67. PubMed ID: 31229934
    [TBL] [Abstract][Full Text] [Related]  

  • 34. How reliable is an undetectable viral load?
    Combescure C; Vallier N; Ledergerber B; Cavassini M; Furrer H; Rauch A; Battegay M; Bernasconi E; Vernazza P; Hirschel B;
    HIV Med; 2009 Sep; 10(8):470-6. PubMed ID: 19459990
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the RealTime HIV-1, COBAS TaqMan 48 v1.0, Easy Q v1.2, and Versant v3.0 assays for determination of HIV-1 viral loads in a cohort of Canadian patients with diverse HIV subtype infections.
    Church D; Gregson D; Lloyd T; Klein M; Beckthold B; Laupland K; Gill MJ
    J Clin Microbiol; 2011 Jan; 49(1):118-24. PubMed ID: 21084515
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Using RT-PCR and bDNA assays to measure non-clade B HIV-1 subtype RNA.
    Pasquier C; Sandres K; Salama G; Puel J; Izopet J
    J Virol Methods; 1999 Aug; 81(1-2):123-9. PubMed ID: 10488770
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low-level viremia associated with the use of TaqMan assay.
    Szabo S; Moffett LE; Cantwell-McNelis K; James CW; Joseph A
    J Int Assoc Physicians AIDS Care (Chic); 2010; 9(4):203-5. PubMed ID: 20530465
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-Term Resolution of Viral Breakthrough after Changing HIV Viral Load Assay.
    Obeid KM; Sural P; Szpunar S; Johnson LB
    J Int Assoc Physicians AIDS Care (Chic); 2011; 10(5):287-90. PubMed ID: 21460355
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Robust PCR Protocol for HIV Drug Resistance Testing on Low-Level Viremia Samples.
    Gupta S; Taylor T; Patterson A; Liang B; Bullard J; Sandstrom P; Van Domselaar G; Ji H
    Biomed Res Int; 2017; 2017():4979252. PubMed ID: 28473986
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Continued production of drug-sensitive human immunodeficiency virus type 1 in children on combination antiretroviral therapy who have undetectable viral loads.
    Persaud D; Siberry GK; Ahonkhai A; Kajdas J; Monie D; Hutton N; Watson DC; Quinn TC; Ray SC; Siliciano RF
    J Virol; 2004 Jan; 78(2):968-79. PubMed ID: 14694128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.